Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02493361
Title Trial of pIL-12/MK-3475 in Metastatic Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alain Algazi
Indications

melanoma

Therapies

Pembrolizumab

IL-12 gene

Age Groups: adult
Covered Countries USA


No variant requirements are available.